-
Our Minor, Novel & Synthetic Cannabinoid series continues with Part IV highlighting the occupational health and safety considerations to make during the manufacture of cannabinoids and provide recommendations for mitigating […]
Join Now
Account Login
- About Us
- Policy & Advocacy
- Take Action: Tell President Trump Marijuana to Deschedule Marijuana
- Take Action: Tell Congress to Protect Medical Marijuana
- Take Action: Stop the Federal Ban on Hemp-Derived THC
- Take Action: Oppose the No Deductions for Marijuana Businesses Act
- NCIA Comments on Federal Marijuana Rescheduling
- Current Issues
- Action Alerts
- NCIA-PAC
- Contact Congress
- Events
- News & Resources
- Membership
- Join The Movement
- NCIA’s Diversity, Equity, and Inclusion Programs
- Member Directory
- NCIA Committees
- Banking & Financial Services Committee (BFSC)
- Cannabis Cultivation Committee (CCC)
- Cannabis Manufacturing Committee (CMC)
- Diversity, Equity & Inclusion Committee (DEIC)
- Education Committee (EC)
- Facilities Design Committee (FDC)
- Hemp Committee (HC)
- Human Resources Committee (HRC)
- Marketing & Advertising Committee (MAC)
- Retail Committee (RC)
- Risk Management & Insurance Committee (RMIC)
- Scientific Advisory Committee (SAC)
- State Regulations Committee (SRC)
- Member Benefits: Market Intelligence & Data
- Member Discounts
- Allied Associations Program
